News

New report released on CDC's Universal Data Collection program

The CDC established a national public health surveillance project called the Universal Data Collection (UDC) system, which was carried out by the CDC and federally funded hemophilia treatment centers (HTCs) from 1998 through 2011.

New report released on CDC's Universal Data Collection program - Read More…

U.S. FDA approves Biogen's hemophilia B drug Alprolix

Biogen Idec, Inc. has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration announced on Friday, March 28, 2014.

U.S. FDA approves Biogen's hemophilia B drug Alprolix - Read More…

Nigerian hematologist receives ISTH fellowship to study at UNC-Chapel Hill

Dr. Helen C. Okoye of Nigeria has received a Reach-the-World Fellowship offered by the International Society on Thrombosis and Haemostasis to receive training at the UNC-Chapel Hill Hemophilia & Thrombosis Center.

Nigerian hematologist receives ISTH fellowship to study at UNC-Chapel Hill - Read More…

7th Symposium on Hemostasis

Old System, New Players, New Directions -- May 15-17, 2014

7th Symposium on Hemostasis - Read More…

UNC researchers create safe and effective synthetic blood thinner

The effects of this new low-molecular-weight synthetic heparin can be quickly reversed, unlike the effects of low-molecular-weight heparin currently in use.

UNC researchers create safe and effective synthetic blood thinner - Read More…

UNC hematologists listed in The Best Doctors in America 2014

UNC hematologists Nigel S. Key, Alice D. Ma, and Stephan Moll are included in the latest compilation of The Best Doctors in America database. Only five percent of doctors in America earn this honor, decided by impartial peer review.

UNC hematologists listed in The Best Doctors in America 2014 - Read More…

UNC hematologist Alice Ma, MD, part of the Choosing Wisely task force

Alice Ma, MD, from the UNC Division of Hematology/Oncology, was on the Choosing Wisely task force for the American Society of Hematology (ASH). ASH recently released a list of the five most common hematologic tests, treatments, and procedures that should be questioned by patients and physicians.

UNC hematologist Alice Ma, MD, part of the Choosing Wisely task force - Read More…

Article on hemophilic pseudotumors by UNC clinicians published by Haemophilia

An article entitled "Clinical features and management of haemophilic pseudotumours: a single US centre experience over a 30-year period" was published in the January 2014 issue of the journal Haemophilia. The authors are UNC clinicians Ming Y. Lim, MBBChir; Brenda Nielsen, MSN; Alice Ma, MD; and Nigel Key, MD.

Article on hemophilic pseudotumors by UNC clinicians published by Haemophilia - Read More…

Tretten approved for rare genetic clotting disorder

On December 23, the U.S. Food and Drug Administration approved Tretten (coagulation factor XIII A-subunit [recombinant]) for use in the routine prevention of bleeding in adults and children who have congenital Factor XIII A-subunit deficiency, a rare clotting disorder.

Tretten approved for rare genetic clotting disorder - Read More…

New gene therapy proves promising as hemophilia treatment

Researchers package specialized blood platelets with genes that express clotting factor, leading to fewer bleeding events.

New gene therapy proves promising as hemophilia treatment - Read More…

Registration opens for 7th UNC Symposium on Hemostasis May 2014

Registration is now open for the 7th UNC Symposium on Hemostasis, May 15-17, 2014, in Chapel Hill. The symposium is entitled "Old System, New Players, New Directions."

Registration opens for 7th UNC Symposium on Hemostasis May 2014 - Read More…

UNC TarHealers walk to raise money for Hemophilia of North Carolina

UNC TarHealers walk to raise money for Hemophilia of North Carolina

The UNC TarHealers walking team raised $1,675 for Hemophilia of North Carolina, the state chapter of the National Hemophilia Foundation.

UNC TarHealers walk to raise money for Hemophilia of North Carolina - Read More…

Clot Connect program featured on CNN

The Clot Connect program was featured prominently in an "Impact Your World" segment on CNN and Headline News.

Clot Connect program featured on CNN - Read More…

Charlene Cowell named as Hemophilia of North Carolina's new Executive Director

On September 27, 2013, Hemophilia of North Carolina Board President Steve Peretti announced that Charlene Cowell has been named as HNC's new Executive Director effective September 19.

Charlene Cowell named as Hemophilia of North Carolina's new Executive Director - Read More…

Harold R. Roberts Hemophilia Treatment Center featured on episodes of "Healthy Body, Healthy Mind"

UNC's Drs. Nigel Key and Alice Ma discuss hemophilia and Drs. Ma and Paul Monahan explain von Willebrand disease on this educational television show.

Harold R. Roberts Hemophilia Treatment Center featured on episodes of "Healthy Body, Healthy Mind" - Read More…

UNC hematology fellow Tyler Buckner, MD, receives NHF-Baxter Clinical Fellowship

Dr. Buckner received a two-year award (July 1, 2013 - June 30, 2015) to support clinical and research training in bleeding and clotting disorders.

UNC hematology fellow Tyler Buckner, MD, receives NHF-Baxter Clinical Fellowship - Read More…

Paul E. Monahan, MD, is honored by National Hemophilia Foundation

Paul E. Monahan, MD, received the Leadership in Research Award from the National Hemophilia Foundation at NHF's 65th anniversary reception in New York City on June 12.

Paul E. Monahan, MD, is honored by National Hemophilia Foundation - Read More…

UNC hematology fellow Ming Lim, MBBChir, receives 2013 ASH Research Training Award for Fellows

Dr. Lim has been chosen as a recipient of the ASH Training Award for Fellows for the period July 1, 2013 - June 30, 2014. The title of her project is "'Contribution of erythrocytes to thrombin generation in sickle cell disease."

UNC hematology fellow Ming Lim, MBBChir, receives 2013 ASH Research Training Award for Fellows - Read More…